Log In
Print
BCIQ
Print
Print this Print this
 

Filgrastim Hexal, Zarzio, filgrastim

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionBiosimilar of human G-CSF
Molecular Target Granulocyte colony-stimulating factor (G-CSF) receptor (CSF3R) (CD114)
Mechanism of ActionGranulocyte colony stimulating factor (G-CSF) receptor (CD114) agonist; Biosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationNeutropenia
Indication DetailsReduce the duration of chemotherapy-induced neutropenia (CIN); Treat neutropenia
Regulatory Designation

EU - Biosimilar (Treat neutropenia);
EU - Biosimilar (Reduce the duration of chemotherapy-induced neutropenia (CIN))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today